U-Blot® Research Grade Efdamrofusp AlfaCat. No. WA2728$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Efdamrofusp AlfaCat. No. WA2728
U-Blot® Research Grade efclarofusp alfaCat. No. WA2727
U-Blot® Research Grade Efbemalenograstim AlfaCat. No. WA2726
U-Blot® Research Grade Efbalropendekin AlfaCat. No. WA2725
U-Blot® Research Grade Efavaleukin alfaCat. No. WA2724
U-Blot® Research Grade efarindodekin alfaCat. No. WA2723
U-Blot® Research Grade Efaprinermin AlfaCat. No. WA2722
U-Blot® Research Grade EfalizumabCat. No. WA2721
U-Blot® Research Grade efadirelaxin alfaCat. No. WA2720
U-Blot® Research Grade EdrecolomabCat. No. WA2719
U-Blot® Research Grade EdobacomabCat. No. WA2718
U-Blot® Research Grade EculizumabCat. No. WA2717